Search Results - Swern AS
- Showing 1 - 1 results of 1
-
1
Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash by Weiss L, Gary D, Swern AS, Freeman J, Sugrue MM
Published 2015Call Number: Loading…Connect to this object online.
Located: Loading…
Book